XML 25 R19.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Significant Accounting Policies (Details 3) (USD $)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Dec. 31, 2010
Consolidation of variable interest entities          
Number of variable interest entities in which the entity is not primary beneficiary     8   8
Comprehensive loss:          
Unrealized holding losses $ (290,000) $ (437,000) $ (550,000) $ (286,000)  
Reclassification adjustment for realized loss included in net loss       (925,000)  
Net loss (17,889,000) (25,154,000) (37,883,000) (34,811,000)  
Comprehensive loss (18,179,000) (25,591,000) (38,433,000) (36,022,000)  
Convertible debt          
Interest rate on convertible debt (as a percent) 2.625%   2.625%    
Regulus Therapeutics Inc.
         
Equity method of accounting          
Principal plus accrued interest guaranteed on Regulus convertible notes $ 5,400,000   $ 5,400,000